Study of ADXS-504 Immunotherapy for Recurrent Prostate Cancer

NCT05077098 · clinicaltrials.gov ↗
PHASE1
Phase
ACTIVE_NOT_RECRUITING
Status
8
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Mark Stein